University of Chicago: Lung Neoplasms trials
The registry lists 13 Lung Neoplasms studies with University of Chicago as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 1 4Phase 2 9No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving LorlatinibNot yet recruitingNCT07782359Phase 1
- A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung CancerRecruitingNCT07603856Phase 2
- Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)RecruitingNCT05068232Phase 2
- Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung CancerTerminatedNCT01803269Phase 2Results posted
- Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLCCompletedNCT01063283Not applicableResults posted
- The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00887315Phase 2Results posted
- Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung CancerTerminatedNCT00203931Phase 2Results posted
- A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid TumorsCompletedNCT02145559Phase 1
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLCTerminatedNCT01063478Phase 1
- Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00025389Phase 2
- Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNCT00005849Phase 2
- Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00005032Phase 1/2
- Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung CancerCompletedNCT00004126Phase 2